Eli Lilly Ugur Sahin covid-19 president RNA vaccine track Eli Lilly Ugur Sahin

Pfizer-BioNTech covid vaccine trial remains on track, says CEO

Reading now: 208
www.livemint.com

Covid-19 vaccine candidate from Pfizer Inc. and BioNTech SE are in line with those seen in smaller early studies, a positive sign for one of the front-runners in the race for a shot.The partners haven’t had to stop their late-stage study over safety concerns, BioNTech Chief Executive Officer Ugur Sahin said in an interview.

They’re sticking with their previously announced target of being able to show as soon as this month whether the vaccine works.That would put Pfizer and BioNTech on track to potentially be the first to show the efficacy of a Covid-19 vaccine, in an environment of intense scrutiny over every possible complication.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA